Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 9

    DCGI releases list of Reference Products for conduct of BE Study, details

    DCGI releases list of Reference Products for conduct of BE Study, details

    Medical Dialogues Bureau25 Jan 2020 8:55 AM
    New Delhi: Through a recent notice, Drug Controller General of India has released the List of Products Permitted by DCG(I) and considered as Reference...
    Patanjali group eyes to be Rs 40,000-crore company in 2020-21

    Patanjali group eyes to be Rs 40,000-crore company in 2020-21

    Medical Dialogues Bureau25 Jan 2020 6:54 AM
    New Delhi: Haridwar-based Patanjali group, which has acquired debt-ridden Ruchi Soya, expects to have a turnover of Rs 35,000-Rs 40,000 crore in the...
    Indian American Pharma millionaire sent to 5.5 years imprisonment for bribery for pushing opioids

    Indian American Pharma millionaire sent to 5.5 years imprisonment for bribery for pushing opioids

    Medical Dialogues Bureau24 Jan 2020 5:00 AM
    Boston: The founder of an Arizona pharmaceutical company was ordered to spend 5 1/2 years in prison Thursday for orchestrating a bribery and kickback...
    Glenmark offloads Indian gynaecology business for Rs 115 crore

    Glenmark offloads Indian gynaecology business for Rs 115 crore

    Medical Dialogues Bureau22 Jan 2020 6:09 AM
    New Delhi: In an attempt to drag down the financial burden, drug giant Glenmark Pharmaceuticals Limited (Glenmark) recently sold off...
    Mumbai: Fake pharmacy call centre selling prescription drugs for impotence busted; 2 held

    Mumbai: Fake pharmacy call centre selling prescription drugs for impotence busted; 2 held

    Farhat Nasim21 Jan 2020 6:10 AM
    Mumbai: In a major crackdown, Mumbai Crime Branch has busted a racket targeting American Nationals and duping them under the pretext of providing...
    Indian Pharmacopoeia Commission to conduct training program for Drug Regulators, others; invites nominations

    Indian Pharmacopoeia Commission to conduct training program for Drug Regulators, others; invites nominations

    MD bureau20 Jan 2020 8:56 AM
    New Delhi: In order to impart training to drugs regulators, drugs analysts and other stakeholders on the issue related to testing, techniques and...
    Biocon chief Kiran Mazumdar Shaw bags Order Of Australia honour

    Biocon chief Kiran Mazumdar Shaw bags Order Of Australia honour

    Medical Dialogues Bureau20 Jan 2020 6:30 AM
    Kiran Mazumdar Shaw, Biocon founder and an Australian Global Alumni Ambassador, is also recognised for her sustained and significant contribution to...
    Drugs and Magic Remedies act to cover online, electronic media; have higher penalties

    Drugs and Magic Remedies act to cover online, electronic media; have higher penalties

    Farhat Nasim19 Jan 2020 5:45 AM
    New Delhi: In a stringent view to regulate the menace of misleading advertisements opted tactfully by many companies to enhance the sale of their...
    Metropolis Healthcare signs binding agreement to buy Shraddha Diagnostics

    Metropolis Healthcare signs binding agreement to buy Shraddha Diagnostics

    Medical Dialogues Bureau18 Jan 2020 6:07 AM
    New Delhi: Pan-India pathology specialist chain Metropolis Healthcare Ltd. has signed a binding agreement to acquire Ahmedabad-based Shraddha...
    FICCI raises concern on delay by govt in notifying E-pharmacy rules

    FICCI raises concern on delay by govt in notifying E-pharmacy rules

    Meghna A Singhania17 Jan 2020 7:03 AM
    NEW DELHI: With the ongoing delay in the notification of e-Pharmacy draft rules, industry body FICCI has recently show concern pointing out that the...
    No discussion on alleged bribes given by pharma firms to doctors at PM Modis meet, claims IPA

    No discussion on alleged bribes given by pharma firms to doctors at PM Modi's meet, claims IPA

    MD bureau16 Jan 2020 6:56 AM
    New Delhi: The Indian Pharmaceutical Alliance (IPA) on Wednesday said Prime Minister Narendra Modi had convened a meeting with the healthcare industry...
    CDSCO declares 450 FDCs as rational, issues directions for manufacturers

    CDSCO declares 450 FDCs as rational, issues directions for manufacturers

    Farhat Nasim15 Jan 2020 7:57 AM
    New Delhi: Apex drug regulator, Central Drugs Standard Control Organization (CDSCO) has recently declared 450 more Fixed-Dose Combination (FDC)...
    PrevNext

    Popular Stories

    Slayback Pharma raises USD 50 million in Series B funding from Everstone Group

    Slayback Pharma raises USD 50 million in Series B funding from Everstone Group

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    KKRs Envision Healthcare hires bank to explore debt restructuring: Report

    KKR's Envision Healthcare hires bank to explore debt restructuring: Report

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Cadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophrenia

    Cadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophrenia

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok